Back to today’s briefing

Story perspectives

Casdin Capital Faces 32% Q1 Drop, Investors Anxious

4/15/2025

50 8

Summary

Story summary

Casdin Capital, a life sciences hedge fund, is grappling with a tough year, suffering a staggering 32% drop in the first quarter. This alarming trend hints at the possibility of a third challenging year in five, leaving investors anxious about the firm's future and its struggle to regain former glory.

1 of 1

Story summary

Casdin Capital, a life sciences hedge fund, is grappling with a tough year, suffering a staggering 32% drop in the first quarter. This alarming trend hints at the possibility of a third challenging year in five, leaving investors anxious about the firm's future and its struggle to regain former glory.